Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

First proof for rituximab in IgG4-related disease
Neuroprotective effect of masitinib in rats with postischemic stroke.
The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study.
Extoxnet (extension toxicology network), 4-aminopyridine
[Nicolau syndrome after administration of glatiramer acetate].
Rituximab Use in Pediatric Central Demyelinating Disease.
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multipl
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.
Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation.
Teva announces FDA acceptance of sNDA for a higher concentration dose of COPAXONE® given three times a week
Copolymer 1 inhibits manifestations of graft rejection.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies.
Roche reports positive studies of MabThera given by subcutaneous injection
Ustekinumab.
New data analyses show significant clinical and MRI improvements with PLEGRIDY™ (peginterferon beta-1a)

Pages